Discontinued Operations - Carrying Value of Major Classes of Assets and Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Assets
Cash and cash equivalents	$ 0	$ 2,223
Discontinued Operations, Held-for-sale
Assets
Cash and cash equivalents		2,223
Other current assets		9,698
Property, plant and equipment, net		51,975
Intangible assets, net		25,274
Investments in affiliates		7,817
Right-of-use assets		13,622
Other noncurrent assets		212
Total assets held for sale		110,821
Liabilities
Deferred revenue, current		8,723
Operating lease liabilities, current		2,459
Other current liabilities		3,099
Deferred revenue, net of current portion		19,410
Operating lease liabilities, net of current portion		12,623
Other long-term liabilities		1,019
Total liabilities held for sale		47,333
TS Biotechnology Sale | Discontinued Operations, Held-for-sale
Assets
Cash and cash equivalents		2,223
Other current assets		9,698
Property, plant and equipment, net		51,975
Intangible assets, net		20,891
Right-of-use assets		13,622
Other noncurrent assets		212
Total assets held for sale		98,621
Liabilities
Deferred revenue, current		8,723
Operating lease liabilities, current		2,459
Other current liabilities		3,058
Deferred revenue, net of current portion		19,410
Operating lease liabilities, net of current portion		12,623
Other long-term liabilities		1,019
Total liabilities held for sale		47,292
EnviroFlight Sale | Discontinued Operations, Held-for-sale
Assets
Cash and cash equivalents		0
Other current assets		0
Property, plant and equipment, net		0
Intangible assets, net		4,383
Investments in affiliates		7,817
Right-of-use assets		0
Other noncurrent assets		0
Total assets held for sale		12,200
Liabilities
Deferred revenue, current		0
Operating lease liabilities, current		0
Other current liabilities		41
Deferred revenue, net of current portion		0
Operating lease liabilities, net of current portion		0
Other long-term liabilities		0
Total liabilities held for sale		41
Related Parties, Aggregated | TS Biotechnology Sale | Discontinued Operations, Held-for-sale
Liabilities
Deferred revenue, current		1,243
Deferred revenue, net of current portion		$ 6,836